Here are six articles published by Becker's Hospital Review in the last week, highlighting Walmart's patent for a floating warehouse, one drugmaker's 430 percent price hike and more.
1. Drugmaker raises price of common diarrhea drug by 430%: 4 things to know
Columbus, Ohio-based West-Ward Pharmaceuticals — the U.S. subsidiary of London-based Hikma Pharmaceuticals — increased the price of a common diarrhea drug by 430 percent.
2. Medtronic Q1 revenue up 3.1%: 5 things to know
Medtronic reported an increase in first quarter revenue for the 2018 fiscal year, which ended July 28.
3. Walmart follows Amazon, applies for aerial warehouse patent
Walmart followed Amazon's endeavor to establish a warehouse in the sky, which would deliver items to consumers via drones.
4. Study reveals electronic reminders did not notably increase medication adherence
Financial incentives, social support and electronic reminders such as wireless pill bottles did not notably improve clinical outcomes or medication adherence among patients following heart attack.
5. Democratic lawmakers launch investigation into high MS drug prices
House Democrats are investigating the high price of multiple sclerosis drugs in the U.S.
6. Price of first FDA-approved ALS treatment in 20 years limits patient access at VCU Medical Center
At the amyotrophic lateral sclerosis clinic at Richmond, Va.-based VCU Medical Center, patient access to the first FDA-approved ALS treatment in 20 years remains limited by restricted insurance coverage and the sheer cost of the drug, according to the Richmond Times Dispatch.
More articles on supply chain:
US Bioservices to pay $13.4M to resolve kickback suit
Patients brace for price of 'breakthrough' leukemia drug CTL019
FDA approves generic version of Cymbalta: 3 things to know